These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35113757)

  • 1. Multimodal Imaging Approach in a Patient with Vogt-Koyanagi-Harada-like Syndrome Due to Dabrafenib and Trametinib Use for Cutaneous Melanoma.
    Bellanca RF; Pinna A; Catania G; Belcastro E; Angi M; D'Amico Ricci G
    Ocul Immunol Inflamm; 2023 Feb; 31(2):402-406. PubMed ID: 35113757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of Vogt-Koyanagi-Harada-like uveitis secondary to dabrafenib/trametinib therapy for advanced melanoma.
    Brambati M; Giuffrè C; Marchese A; Bandello F; Modorati GM; Miserocchi E
    Eur J Ophthalmol; 2022 Jan; 32(1):NP109-NP113. PubMed ID: 32998540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DRB1*04:05 in two cases of Vogt-Koyanagi-Harada disease-like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/trametinib therapy.
    Fujimura T; Kambayashi Y; Tanita K; Sato Y; Hidaka T; Otsuka A; Tanaka H; Furudate S; Hashimoto A; Aiba S
    J Dermatol; 2018 Jun; 45(6):735-737. PubMed ID: 29488243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vogt-Kayanagi-Harada-Like Uveitis Induced by Dabrafenib/Trametinib Therapy for Cutaneous Malignant Melanoma.
    Kaymak NZ; Kaplan AT
    Ophthalmic Surg Lasers Imaging Retina; 2023 Aug; 54(8):477-480. PubMed ID: 37535619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VOGT-KOYANAGI-HARADA DISEASE-LIKE UVEITIS IN A PATIENT WITH ADVANCED MELANOMA TREATED BY SEQUENTIAL ADMINISTRATION OF NIVOLUMAB AND DABRAFENIB/TRAMETINIB THERAPY.
    Madoe A; Schauwvlieghe PP; Jacob J
    Retin Cases Brief Rep; 2023 Sep; 17(5):611-615. PubMed ID: 37643052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case Report and Literature Review of Vogt-Koyanagi-Harada-Like Uveitis Secondary to Dabrafenib and Trametinib: 4-Year Follow-Up Using Retinal Multimodal Imaging.
    Ucan Gunduz G; Gullulu ZZ; Nizam Tekcan S; Yalcinbayir O; Cubukcu E
    Ocul Immunol Inflamm; 2024 Dec; 32(10):2589-2593. PubMed ID: 39250693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case with metastatic cutaneous malignant melanoma that developed Vogt-Koyanagi-Harada-like uveitis following pembrolizumab treatment.
    Enomoto H; Kato K; Sugawara A; Itabashi M; Kondo M
    Doc Ophthalmol; 2021 Jun; 142(3):353-360. PubMed ID: 33392895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: Ipilimumab-induced Multisystem Autoimmune-like Toxicities Suggestive of Vogt-Koyanagi-Harada-like Syndrome.
    Monferrer-Adsuara C; Hernández-Bel L; Hernández-Garfella ML; Remolí-Sargues L; Ortiz-Salvador M; Castro-Navarro V; Cervera-Taulet E
    Optom Vis Sci; 2021 Nov; 98(11):1309-1316. PubMed ID: 34510146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vogt-Koyanagi-Harada disease-like uveitis induced by vemurafenib for metastatic cutaneous malignant melanoma.
    Fusumae T; Kamiya K; Maekawa T; Komine M; Murata S; Inoda S; Takahashi R; Kawashima H; Ohtsuki M
    J Dermatol; 2018 Jun; 45(6):e159-e160. PubMed ID: 29314171
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of Acute Vogt-Koyanagi-Harada-like Syndrome during the Treatment Course with Vemurafenib for Metastatic Melanoma.
    Apivatthakakul A; Kunavisarut P; Rothova A; Pathanapitoon K
    Ocul Immunol Inflamm; 2020 Apr; 28(3):505-508. PubMed ID: 31161956
    [No Abstract]   [Full Text] [Related]  

  • 11. VOGT-KOYANAGI-HARADA-LIKE UVEITIS FOLLOWED BY MELANOMA-ASSOCIATED RETINOPATHY WITH FOCAL CHORIORETINAL ATROPHY AND CHOROIDAL NEOVASCULARIZATION IN A PATIENT WITH METASTATIC CUTANEOUS MELANOMA.
    Ng CC; Alsberge JB; Qian Y; Freund KB; Cunningham ET
    Retin Cases Brief Rep; 2023 Jan; 17(1):18-22. PubMed ID: 33394953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of intravitreal dexamethasone implant in the management of «Vogt-Koyanagi-Harada-like syndrome» secondary to map kinase pathway inhibition.
    Campos Polo R; García Guisado D; Rubio Sánchez C; Márquez Ivacevich NT
    Arch Soc Esp Oftalmol (Engl Ed); 2020 Oct; 95(10):501-506. PubMed ID: 32593600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vogt-Koyanagi-Harada-like uveitis under immune checkpoint inhibitor treatment for metastasized malignant melanoma].
    Mihailovic N; Dyballa J; Herz S; Fluck M; Alnawaiseh M; Merté RL; Eter N
    Ophthalmologe; 2020 May; 117(5):467-471. PubMed ID: 31489479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vogt-Koyanagi-Harada-like Syndrome Induced by Checkpoint Inhibitor Cemiplimab.
    Huang Y; Khan F; Saraiya NV; Punjabi OS; Gulati V; Erickson AR; Yeh S
    J Immunother; 2023 Oct; 46(8):295-298. PubMed ID: 37315200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VKH-like syndrome in the setting of Dabrafenib and Trametinib therapy for BRAF mutant metastatic melanoma: a case report.
    Gunaratnam C; Muzicenco O; Sivagurunathan P; Franzco MH
    J Surg Case Rep; 2024 Mar; 2024(3):rjae104. PubMed ID: 38455982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Ipilimumab-Induced Vogt-Koyanagi-Harada Syndrome With Oral Dexamethasone.
    Witmer MT
    Ophthalmic Surg Lasers Imaging Retina; 2017 Nov; 48(11):928-931. PubMed ID: 29121363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of B Cell Depletion Therapy with Rituximab in Refractory Chronic Recurrent Uveitis Associated with Vogt-Koyanagi-Harada Disease.
    Abu El-Asrar AM; Dheyab A; Khatib D; Struyf S; Van Damme J; Opdenakker G
    Ocul Immunol Inflamm; 2022 Apr; 30(3):750-757. PubMed ID: 32990482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent Vogt-Koyanagi-Harada disease and impressive response to immune checkpoint blockade in metastatic melanoma.
    Gambichler T; Seifert C; Lehmann M; Lukas C; Scheel C; Susok L
    Immunotherapy; 2020 May; 12(7):439-444. PubMed ID: 32308086
    [No Abstract]   [Full Text] [Related]  

  • 19. Vogt-Koyanagi-Harada syndrome-like uveitis after nivolumab administration as a treatment for ovarian cancer.
    Hwang GE; Lee JW; Jeon S; Cho IH; Kim HD
    Doc Ophthalmol; 2022 Apr; 144(2):153-162. PubMed ID: 34997406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vogt Koyanagi Harada syndrome in a 15-year-old girl, steroids side effects and recurrences.
    Yıldırım G; Çavdarlı C; Özdemir EY; Alp MN
    Turk J Pediatr; 2021; 63(3):527-532. PubMed ID: 34254501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.